Back to Search Start Over

Pharmacogenomics at the center of precision medicine: challenges and perspective in an era of Big Data.

Authors :
Primorac D
Bach-Rojecky L
Vađunec D
Juginović A
Žunić K
Matišić V
Skelin A
Arsov B
Boban L
Erceg D
Ivkošić IE
Molnar V
Ćatić J
Mikula I
Boban L
Primorac L
Esquivel B
Donaldson M
Source :
Pharmacogenomics [Pharmacogenomics] 2020 Jan; Vol. 21 (2), pp. 141-156. Date of Electronic Publication: 2020 Jan 17.
Publication Year :
2020

Abstract

Pharmacogenomics (PGx) is one of the core elements of personalized medicine. PGx information reduces the likelihood of adverse drug reactions and optimizes therapeutic efficacy. St Catherine Specialty Hospital in Zagreb/Zabok, Croatia has implemented a personalized patient approach using the RightMed <superscript>®</superscript> Comprehensive PGx panel of 25 pharmacogenes plus Facor V Leiden, Factor II and MTHFR genes, which is interpreted by a special counseling team to offer the best quality of care. With the advent of significant technological advances comes another challenge: how can we harness the data to inform clinically actionable measures and how can we use it to develop better predictive risk models? We propose to apply the principles artificial intelligence to develop a medication optimization platform to prevent, manage and treat different diseases.

Details

Language :
English
ISSN :
1744-8042
Volume :
21
Issue :
2
Database :
MEDLINE
Journal :
Pharmacogenomics
Publication Type :
Academic Journal
Accession number :
31950879
Full Text :
https://doi.org/10.2217/pgs-2019-0134